Comparison of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines) with several other inhibitors of mitosis.
暂无分享,去创建一个
W. Waud | W R Waud | G. P. Wheeler | C Temple | B J Bowdon | G P Wheeler | R Hain | L Dansby | L. Dansby | C. Temple | B. Bowdon | R. Hain
[1] L. Wilson. Properties of colchicine binding protein from chick embryo brain. Interactions with vinca alkaloids and podophyllotoxin. , 1970, Biochemistry.
[2] P. Schiff,et al. Steganacin: an inhibitor of HeLa cell growth and microtubule assembly in vitro. , 1978, Biochemical and biophysical research communications.
[3] G. P. Wheeler,et al. 1-Deaza-7,8-dihydropteridines, a new class of mitotic inhibitors with anticancer activity. , 1981, Biochemical pharmacology.
[4] V. Sethi,et al. Binding of maytansinoids to tubulin. , 1981, Biochemical pharmacology.
[5] E. Hamel,et al. Interactions of a new antimitotic agent, NSC-181928, with purified tubulin. , 1982, Biochemical and biophysical research communications.
[6] L. C. Davidse,et al. Differential binding of methyl benzimidazol-2-yl carbamate to fungal tubulin as a mechanism of resistance to this antimitotic agent in mutant strains of Aspergillus nidulans , 1977, The Journal of cell biology.
[7] B. Bhattacharyya,et al. Maytansine binding to the vinblastine sites of tubulin , 1977, FEBS letters.
[8] S. M. Kupchan,et al. Antimitotic and antitubulin activity of the tumor inhibitor steganacin. , 1977, Cancer research.
[9] R. Himes,et al. Direct photoaffinity labeling of tubulin with guanosine 5'-triphosphate. , 1985, Biochemistry.
[10] D. Murphy. Assembly-disassembly purification and characterization of microtubule protein without glycerol. , 1982, Methods in cell biology.
[11] T. Arai. Inhibition of microtubule assembly in vitro by TN‐16, a synthetic antitumor drug , 1983, FEBS letters.
[12] D. J. Adamson,et al. Biological effects and structure-activity relationships of 1,2-dihydropyrido[3,4-b]pyrazines. , 1983, Cancer research.
[13] T. Chou,et al. The binding of colchicine by sarcoma 180 cells. , 1968, Biochemical pharmacology.
[14] J. Montgomery,et al. 1,2-Dihydropyrido[3,4-b]pyrazines: structure-activity relationships. , 1983, Journal of Medicinal Chemistry.
[15] D. J. Adamson,et al. Inhibition of mitosis and anticancer activity against experimental neoplasms by ethyl 5-amino-1,2-dihydro-3-[(N-methylanilino)methyl]-pyrido[3,4-b]pyrazin-7-ylcarbamate (NSC 181928). , 1982, Cancer research.
[16] M. De Brabander,et al. Interaction of oncodazole (R 17934), a new antitumoral drug, with rat brain tubulin. , 1976, Biochemical and biophysical research communications.
[17] J P Laclette,et al. Inhibition of tubulin polymerization by mebendazole. , 1980, Biochemical and biophysical research communications.
[18] D. Johns,et al. Binding of maytansine to rat brain tubulin. , 1976, Biochemical and biophysical research communications.
[19] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.